Department of Ophthalmology, Hietzing Hospital
Vienna, 1130, Austria
NCT Number: NCT00612781
Blue-light-filtering IOLs are implanted increasingly often in cataract surgery. Several studies examined the effect of blue-light-filters on contrast and colour vision. However, the study outcomes were varying. The present study investigated the effect of a blue-light-filtering IOL on colour perception and contrast acuity using highly sensitive measurement methods.
Looking for future studies?
Notify Me55 year–80 year
All sexes
Interventional
Phase 4
Vienna, 1130, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
implantation of a yellow Hoya AF-1 (UY) YA-60BB intraocular lens
Other names: Hoya AF-1 (UY) YA-60BB
implantation of an uncoloured Hoya AF-1 (UV) VA-60BB
Other names: Hoya AF-1 (UV) VA-60BB
Time frame: 3 month after surgery
Time frame: 3 month after surgery
Time frame: 3 month after surgery
Hospital Hietzing
Other
Influence of Blue-Light-Filter IOLs on Color Perception and Contrast Acuity. A Randomized, Double-Masked Study With Intraindividual Comparison.
Acronym: YeWhi
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735000
Age Related Cataract, Cataract
Peshawar, KPK, Pakistan
View Trial DetailsNCT07605260
Cataract, Eye Diseases
Islamabad, Punjab Province, Pakistan
View Trial DetailsNCT06428955
Cataract, Eye Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT06111222
Cataract, Eye Diseases
Heidelberg, Germany
View Trial Details